Telesis Bio

San Diego, United States

Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA.

$74.2M raised

May 2023

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Telesis Bio raised?

Telesis Bio has raised $74.2M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2023.

Who are Telesis Bio's investors?

Telesis Bio's investors include Novalis LifeSciences, Northpond Ventures, BroadOak Capital Partners, M-185 Corporation.

Where is Telesis Bio headquartered?

Telesis Bio is headquartered in San Diego, United States.

What does Telesis Bio do?

Telesis Bio is a biotech company that empowers researchers with the tools to secure design, code, and create synthetic DNA and mRNA.

What stage is Telesis Bio at?

Telesis Bio is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 31, 2023.

MLA

"Telesis Bio — Funding & Investors." VCBacked, May 31, 2023, https://www.vcbacked.co/company/telesis-bio. Accessed July 2, 2026.

APA

VCBacked. (2023). Telesis Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/telesis-bio

Wikipedia (cite web)

{{cite web |title=Telesis Bio — Funding & Investors |url=https://www.vcbacked.co/company/telesis-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 31, 2023.